From TNF Cycling to JAK Inhibitors: Interpreting Evidence to Improve Outcomes in Rheumatoid Arthritis

New evidence on switching from tumor necrosis factor (TNF) to Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA).

Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/tnf-cycling-jak-inhibitors-interpreting-evidence-improve-2026a100130o?ecd=bdc_podcast_libsyn_mscpedu